Ozari Health review
Eighty-six dollars a month for compounded semaglutide is one of the lowest figures anywhere on this page, and $125 for tirzepatide is genuinely cheap for the dual agonist. What sits under those numbers is the problem. Each card carries an average — "Average 15-20% body weight loss" on semaglutide, "Average 20-25%" on tirzepatide. The top of that second range is higher than tirzepatide managed at its maximum dose in its own registrational trial, and these are compounded products that were never in one.
- Independently scored
- Verified
Every medical claim in this piece is footnoted to the record it came from — the trial or the FDA label — so you can read the source rather than take the masthead's word for it. No one on this desk is your clinician.
Ozari Health at a glance
- Semaglutide
- From $86/mo
- Tirzepatide
- From $125/mo
- Coverage
- Not published on the site
- Brand-name
- Compounded only
How we scored Ozari Health
Each score comes out of Ozari Health's published pricing, disclosures and oversight, and the six combine into the 45/100 Editors' Rating on the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
The headline rate obscures a plan requirement or a hidden step-up.
Cost is unpredictable, premium, or hides behind a plan commitment.
Little here is shaped around a mother's week or her life stage.
Support is thin once the prescription ships.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
Leaving costs you — notice windows, minimum terms or fees you don't get back.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
- Primary source
- ozarihealth.com
Read from Ozari Health's own pages in August 2026. Compounded semaglutide starts at $86 a month and tirzepatide at $125 — among the lowest published figures on this roster, with free shipping included and dosage described as doctor-monitored. Each price card carries a results claim directly beneath it: "Average 15-20% body weight loss" for semaglutide and "Average 20-25%" for tirzepatide. The top of that tirzepatide range is higher than tirzepatide reached at its maximum dose in its own registrational trial, and both are compounded products that were never in one. No list of states, no street address and no compounding pharmacy appear anywhere on the site.
What to expect when you sign up
We walked Ozari Health's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1The signup call to action leaves ozarihealth.com for app.ozarihealth.com, a separate host
- 2The intake responded HTTP 200 when checked on 2026-08-21
- 3Walked to the intake entry only. No personal information was submitted, so nothing past the entry screen is asserted here
What we noticed
- The intake runs on Bask Health rather than on the provider's own software
- A monthly price is visible on the public homepage before any intake — you do not have to hand over information to see a number
- Intake is hosted on app.ozarihealth.com, so the company you fill the form in with is not the domain you started on
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $86 | Starting price"Semaglutide, Compounded GLP-1 medication, Starting at $86 /per month", with free discreet shipping included. |
| Compounded tirzepatide | $125 | Starting price"Tirzepatide, Compounded dual GIP/GLP-1 medication, Starting at $125 /per month." |
Swipe the table to see plan details →
GLP-1 telehealth is usually HSA- and FSA-eligible, so check your own plan. Everything above comes from Ozari Health's public disclosures at last review and change often; confirm the current number on Ozari Health's own site.
What we like
- Among the lowest published prices on this roster for both molecules
- Prices each molecule separately rather than under one "starting at" figure
- Free discreet shipping included, with dosage described as doctor-monitored
- Names its operating entity, Ozari LLC, in its own terms
The caveats
- "Average 20-25% body weight loss" on the tirzepatide card exceeds what tirzepatide reached at its highest dose in a controlled trial, and this is a compounded product
- "Average 15-20%" on the semaglutide card is likewise an average rather than a trial ceiling
- Both prices are "starting at", so dose may move them
- No list of states served
- No compounding pharmacy is named
- No street address appears anywhere
Ozari Health for mothers: our verdict
Eighty-six dollars a month for compounded semaglutide is one of the lowest figures anywhere on this page, and $125 for tirzepatide is genuinely cheap for the dual agonist. What sits under those numbers is the problem. Each card carries an average — "Average 15-20% body weight loss" on semaglutide, "Average 20-25%" on tirzepatide. The top of that second range is higher than tirzepatide managed at its maximum dose in its own registrational trial, and these are compounded products that were never in one. It runs about $86/month — toward the affordable end of what we track.
We weigh Ozari Health the way mothers actually have to: not just the real monthly cost, but the real monthly cost once the dose climbs and whether a real clinician stands behind it — the things a generic roundup never gets to.
What Ozari Health actually costs
- Compounded semaglutide — Starting price: $86/mo
- Compounded tirzepatide — Starting price: $125/mo
That sits below the roughly $179 median ongoing price across the providers we track for mothers — a real cost advantage.
The medications Ozari Health prescribes
Ozari Health prescribes semaglutide and tirzepatide — the pair with the strongest evidence behind them, and having both under one account matters when insulin resistance, familiar from PCOS and gestational diabetes, makes tirzepatide the better fit. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
Where Ozari Health fits — and where it doesn't — for mothers
Worth it if…
- you want a real clinician reading your history around the real monthly cost once the dose climbs, not an auto-approving quiz.
- the real monthly cost is a real barrier and you want a low, predictable number.
- you may need to move between semaglutide and tirzepatide as your body and hormones change.
Give it a miss if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- you'd rather a prescriber talk through timing around the real monthly cost once the dose climbs — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety, and oversight
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our Editors' Rating methodology.
A standing caveat for mothers: GLP-1 medications aren't established as safe during pregnancy or breastfeeding, and every label advises against use. Nothing here changes that — plan the timing with your own clinician.
The bottom line
Ozari Health is a genuine value play — weigh it on the real monthly cost once the dose climbs and whether a real clinician stands behind it against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: A budget that needs the lowest number available, with the results claims set aside entirely.
Alternatives to Ozari Health
Providers we have a referral relationship with, ordered by their Editors' Rating — highest first. A fee never moves a rating, but it does decide who appears here, so this is not the whole roster: the full ranking lists every provider we cover.
- Visit CoreAge RxCoreAge RxOur #1 pick
The one program on this masthead whose number still makes sense at the top of the dose. A flat, all-in monthly price on both molecules, no teaser rate to expire, and a cancel button you can actually find — the closest thing to a family-budget guarantee we've reviewed.
- Visit Gala Health
A flat $179 for either molecule and a genuinely gentle microdosing tier — a reasonable, all-doses-included option, if you can live with a yearly plan and a pharmacy the marketing never names.
- Visit Sesame
A high-trust telehealth marketplace that took a clear side: FDA-approved brand GLP-1 only, no compounded shortcut. You pay a brand cash price and book a real video visit — but you get on-label pens and one of the cleaner reputations on this masthead.
Keep comparing Ozari Health
Head-to-head & alternatives
Ozari Health, answered
- How much does Ozari Health cost?
- When we last checked, the cheapest ongoing compounded price at Ozari Health was around $86 a month: From $86/mo for semaglutide and From $125/mo for tirzepatide. Prices here move quickly — confirm today's all-in number on their own site before signing up.
- Is Ozari Health safe to use while breastfeeding?
- No GLP-1 has been shown to be safe in pregnancy or while nursing, whether compounded or brand-name, and the labeling advises against it. That applies to Ozari Health as much as to anyone else. Time it for after weaning, and make the decision with your own clinician.
- Does Ozari Health offer both semaglutide and tirzepatide?
- Yes — Ozari Health offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
- Where does Ozari Health rank for mothers?
- Ozari Health takes 45/100 in our Editors' Rating, placing it #229. Six factors chosen for mothers feed that number, and CoreAge Rx is the one at the top of the list — see how they compare.
Pricing, states and verification reflect Ozari Health's public disclosures at last review; the Editors' Rating is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.